TIVC SCHEDULE 13D/A: SEC filing
Filed with the SEC on · accession 0001753926-26-001719
TIVC filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Sep 3, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
3i, LP purchased 3,004 shares of Valion Bio, Inc. common stock on September 3, 2026 at $2.8808 per share, as disclosed in an amendment to its Schedule 13D.
Key details
✦ Ask GOAX AI about this filing — what it means for TIVC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TIVC?
Click hereFrequently asked questions
What did TIVC file with the SEC on Sep 3, 2026?
TIVC filed a SCHEDULE 13D/A (SEC filing). 3i, LP purchased 3,004 shares of Valion Bio, Inc. common stock on September 3, 2026 at $2.8808 per share, as disclosed in an amendment to its Schedule 13D.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
Other TIVC SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · SEC filingNov 2, 2026
- 8-K · Fda approvalOct 29, 2026
- 8-K · Material agreementOct 27, 2026
- 8-K · DivestitureOct 26, 2026
- 8-K · Ceo changeOct 22, 2026
- 424B3 · Shelf registrationOct 21, 2026
- EFFECT · Shelf registrationOct 20, 2026
- EFFECT · SEC filingOct 20, 2026
- DEF 14A · Stock splitOct 16, 2026
Get alerts when TIVC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days